Pages that link to "Q34122417"
Jump to navigation
Jump to search
The following pages link to Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials (Q34122417):
Displaying 50 items.
- Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials (Q21132402) (← links)
- The metabolic vascular syndrome - guide to an individualized treatment (Q26767142) (← links)
- Aspirin for primary prevention of cardiovascular disease (Q26774150) (← links)
- New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism (Q26786574) (← links)
- The failure of cancer chemoprevention (Q26822900) (← links)
- Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes (Q26853571) (← links)
- What is good for the circulation also lessens cancer risk (Q26859261) (← links)
- Evolving management of symptomatic chronic subdural hematoma: experience of a single institution and review of the literature (Q26862513) (← links)
- A systematic review of aspirin in primary prevention: is it time for a new approach? (Q26864015) (← links)
- Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events (Q26995752) (← links)
- Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9. (Q27333563) (← links)
- Use of medications and lifestyles of hypertensive patients with high risk of cardiovascular disease in rural China (Q28546905) (← links)
- A 16-month community-based intervention to increase aspirin use for primary prevention of cardiovascular disease. (Q33622632) (← links)
- Aspirin for primary cardiovascular prevention: when is it worth the risks? (Q33774734) (← links)
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials (Q34263014) (← links)
- Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status. (Q34433987) (← links)
- Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine. (Q34901444) (← links)
- How confidence intervals become confusion intervals (Q35028969) (← links)
- Do clinicians recommend aspirin to patients for primary prevention of cardiovascular disease? (Q35040366) (← links)
- Aspirin for primary prevention: what's a clinician to do? (Q35040398) (← links)
- The role of aspirin in the prevention of cardiovascular disease (Q35049359) (← links)
- Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients (Q35072103) (← links)
- Aspirin use and knowledge in the community: a population- and health facility based survey for measuring local health system performance (Q35089003) (← links)
- Long-term mortality risk in individuals with atrial or ventricular premature complexes (results from the Third National Health and Nutrition Examination Survey). (Q35102024) (← links)
- How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusion (Q35214488) (← links)
- Advances in the prevention of Alzheimer's disease and dementia (Q35322167) (← links)
- Current antiplatelet treatment strategy in patients with diabetes mellitus (Q35544048) (← links)
- Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis (Q35546421) (← links)
- Association between Aspirin Therapy and Clinical Outcomes in Patients with Non-Obstructive Coronary Artery Disease: A Cohort Study (Q35650038) (← links)
- Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis (Q35685250) (← links)
- Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women (Q35953560) (← links)
- Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews (Q36082805) (← links)
- Cancers prevented in Australia in 2010 through the consumption of aspirin. (Q36164408) (← links)
- The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older (Q36207970) (← links)
- Immune activation and cardiovascular disease in chronic HIV infection (Q36556082) (← links)
- Is Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin? (Q36591180) (← links)
- Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis (Q36668917) (← links)
- Correlation between Platelet Gelsolin and Platelet Activation Level in Acute Myocardial Infarction Rats and Intervention Effect of Effective Components of Chuanxiong Rhizome and Red Peony Root (Q36711580) (← links)
- Primary prophylactic aspirin use and incident stroke: reasons for geographic and racial differences in stroke study (Q36850971) (← links)
- Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial (Q37019565) (← links)
- Using an Electronic Decision Support Tool to Reduce Inappropriate Polypharmacy and Optimize Medicines: Rationale and Methods (Q37037861) (← links)
- Advances in our understanding of "resistance" to antiplatelet agents for prevention of ischemic stroke (Q37051838) (← links)
- Low-dose aspirin use and cancer characteristics: a population-based cohort study (Q37214225) (← links)
- Effect of including cancer mortality on the cost-effectiveness of aspirin for primary prevention in men (Q37231429) (← links)
- Positive influence of aspirin on coronary endothelial function: Importance of the dose (Q37378488) (← links)
- AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol (Q37598223) (← links)
- Primary Prevention of Atherosclerotic Cardiovascular Disease in Women (Q37613887) (← links)
- The role of carotid ultrasound for cardiovascular risk stratification beyond traditional risk factors (Q37708256) (← links)
- Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. (Q37996239) (← links)
- Aspirin for primary prevention of cardiovascular events in the elderly: current status and future directions (Q37998509) (← links)